Drugs / ETIMS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01414634 | Feb 2010 → Oct 2012 | relapsing-remitting multiple sclerosis | University Medical Center Hamburg-Eppendorf | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ETIMS | “Biological: ETIMS” NCT01414634 ↗ |
| Modality | Cell therapy | “autologous peripheral blood mononuclear cells chemically coupled with seven myelin peptides” NCT01414634 ↗ |
| Route | Intravenous | “injection of peptide-coupled PBMC by i.v. infusion” NCT01414634 ↗ |